Tectonic Therapeutic (TECX) closed at $21.04 on November 12, 2026, down 4.2% from the previous close, on volume of 116,785 shares (30-day average 185,769).
Data as of November 12, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 11, 2026. See the 10 largest for 30, 60 and 90 days
Tectonic Therapeutic to Participate in Upcoming Investor Conferences
Globe Newswire (Mon, 9-Nov 8:00 AM ET)
Tectonic Therapeutic Announces Third Quarter 2026 Financial Results and Recent Business Highlights
Globe Newswire (Thu, 5-Nov 4:01 PM ET)
Globe Newswire (Tue, 29-Sep 8:00 AM ET)
Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference
Globe Newswire (Thu, 3-Sep 8:00 AM ET)
Market Chameleon (Thu, 30-Oct 6:39 AM ET)
Tectonic Therapeutics Skyrockets 92.5% on Positive Interim Data for TX45
Market Chameleon (Thu, 30-Jan 7:16 AM ET)
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Tectonic Therapeutic trades on the NASDAQ stock market under the symbol TECX.
As of November 12, 2026, TECX stock price declined to $21.04 with 116,785 million shares trading.
TECX has a beta of 0.33, meaning it tends to be less sensitive to market movements. TECX has a correlation of 0.00 to the broad based SPY ETF.
TECX has a market cap of $411.32 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that TECX belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.
TECX has underperformed the market in the last year with a return of +10.9%, while the SPY ETF gained +12.0%. In the last 3 month period, TECX fell short of the market, returning -34.0%, while SPY returned -1.5%. However, in the most recent 2 weeks TECX has outperformed the stock market by returning +2.3%, while SPY returned -2.0%.
TECX support price is $21.16 and resistance is $22.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TECX shares will trade within this expected range on the day.
